Tech Company Financing Transactions
Xilio Therapeutics Funding Round
Xilio Therapeutics secured a $100.5 million Series B funding round on 3/3/2020. Investors included Takeda Ventures, Atlas Venture and Bay City Capital.
Transaction Overview
Takeda Ventures (Lead Investor) (Jayson Punwani)
Atlas Venture (David Grayzel)
F-Prime Capital (Benjamin Auspitz)
MRL Ventures (Peter Dudek)
RiverVest Venture Partners (Nancy Hong)
SV Health Investors (Michael Ross)
Company Information
Waltham, MA 02451
USA
Management Team
Browse more venture capital transactions:
Prev: 3/3/2020: Thought Machine venture capital transaction
Next: 3/3/2020: Immunocore venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs